Quantitative monitoring of mouse lung tumors by magnetic resonance imaging

Nature Protocols

Volumn 7, Issue 1, 2012, Pages 128-142

  Krupnick, Alexander Sasha ^a   Tidwell, Vanessa K ^b   Engelbach, John A ^c   Alli, Vamsi V ^a   Nehorai, Arye ^b   You, Ming ^d   Vikis, Haris G ^d   Gelman, Andrew E ^a   Kreisel, Daniel ^a   Garbow, Joel R ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE PROCESSING; LUNG CANCER; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TUMOR VOLUME;

ANIMALS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL;

ANIMALIA; RODENTIA;

EID: 84861124351     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2011.424     Document Type: Article

References (60)

1. Ghetie, C., Davies, M., Cornfeld, D., Suh, N. & Saif, M.W. Expectoration of a lung metastasis in a patient with colorectal carcinoma. Clin. Colorectal Cancer 7, 283-286 (2008).
2. Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics, 2010. CA Cancer J. Clin. 60, 277-300 (2010).
3. Leong, S.P. et al. Clinical patterns of metastasis. Cancer Metastasis Rev. 25, 221-232 (2006). (Pubitemid 43890716)
4. Hodi, F.S. et al. Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc. Natl. Acad. Sci. USA 105, 3005-3010 (2008). (Pubitemid 351723658)
5. Hodi, F.S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711-723 (2010).
6. van Elsas, A., Hurwitz, A.A. & Allison, J.P. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J. Exp. Med. 190, 355-366 (1999). (Pubitemid 29374833)
7. Bui, J.D., Uppaluri, R., Hsieh, C.S. & Schreiber, R.D. Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins. Cancer Res. 66, 7301-7309 (2006). (Pubitemid 44197712)
8. Cramer, D.W. & Finn, O.J. Epidemiologic perspective on immune-surveillance in cancer. Curr. Opin. Immunol. 23, 265-271 (2010).
9. Bienenstock, J. T cells and the immune response: down-regulation via mucosal exposure. Can. Respir. J. 5 (suppl A), 27A-30A (1998). (Pubitemid 128708510)
10. Liu, P. et al. Candidate lung tumor susceptibility genes identifed through whole-genome association analyses in inbred mice. Nat. Genet. 38, 888-895 (2006). (Pubitemid 44141656)
11. Fushiki, H. et al. Quantifcation of mouse pulmonary cancer models by microcomputed tomography imaging. Cancer Sci. 100, 1544-1549 (2009).
12. Guilbaud, N. et al. Antitumor activity of S 16020-2 in two orthotopic models of lung cancer. Anticancer Drugs 8, 276-282 (1997). (Pubitemid 27157938)
13. Feldser, D.M. et al. Stage-specifc sensitivity to p53 restoration during lung cancer progression. Nature 468, 572-575 (2010).
14. DuPage, M. et al. Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression. Cancer Cell 19, 72-85 (2011).
15. Johnson, L. et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410, 1111-1116 (2001). (Pubitemid 32391044)
16. DuPage, M., Dooley, A.L. & Jacks, T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat. Protoc. 4, 1064-1072 (2009).
17. Cheung, A.F., Dupage, M.J., Dong, H.K., Chen, J. & Jacks, T. Regulated expression of a tumor-associated antigen reveals multiple levels of T-cell tolerance in a mouse model of lung cancer. Cancer Res. 68, 9459-9468 (2008).
18. Barbie, D.A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108-112 (2009).
19. Kim, C.F. et al. Mouse models of human non-small-cell lung cancer: raising the bar. Cold Spring Harb. Symp. Quant. Biol. 70, 241-250 (2005). (Pubitemid 44124878)
20. Kirsch, D.G. et al. Imaging primary lung cancers in mice to study radiation biology. Int. J. Radiat. Oncol. Biol. Phys. 76, 973-977 (2010).
21. Lubet, R.A., Zhang, Z., Wang, Y. & You, M. Chemoprevention of lung cancer in transgenic mice. Chest 125, 144S-147S (2004). (Pubitemid 38648358)
22. Acuff, H.B., Carter, K.J., Fingleton, B., Gorden, D.L. & Matrisian, L.M. Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Res. 66, 259-266 (2006). (Pubitemid 43166032)
23. Deroose, C.M. et al. Multimodality imaging of tumor xenografts and metastases in mice with combined small-animal PET, small-animal CT, and bioluminescence imaging. J. Nucl. Med. 48, 295-303 (2007). (Pubitemid 47555357)
24. van Klaveren, R.J. et al. Management of lung nodules detected by volume CT scanning. N. Engl. J. Med. 361, 2221-2229 (2009).
25. Aberle, D.R. et al. The National Lung Screening Trial: overview and study design. Radiology 258, 243-253 (2010).
26. Namati, E. et al. Longitudinal assessment of lung cancer progression in the mouse using in vivo micro-CT imaging. Med. Phys. 37, 4793-4805 (2010).
27. Paulus, M.J., Gleason, S.S., Kennel, S.J., Hunsicker, P.R. & Johnson, D.K. High-resolution X-ray computed tomography: an emerging tool for small animal cancer research. Neoplasia 2, 62-70 (2000). (Pubitemid 30123181)
28. Kozin, S.V. et al. Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation. Cancer Res. 70, 5679-5685 (2010).
29. Yuan, S., Qiao, T. & Chen, W. CpG oligodeoxynucleotide 1826 enhances the Lewis lung cancer response to radiotherapy in murine tumor. Cancer Biother. Radiopharm. 26, 203-208 (2011).
30. Peranteau, W.H., Hayashi, S., Hsieh, M., Shaaban, A.F. & Flake, A.W. High-level allogeneic chimerism achieved by prenatal tolerance induction and postnatal nonmyeloablative bone marrow transplantation. Blood 100, 2225-2234 (2002). (Pubitemid 35001260)
31. + T cells during homeostatic proliferation requires CD4+ T cells. Nat. Immunol. 7, 475-481 (2006).
32. Shvets, A. et al. Impaired negative regulation of homeostatically proliferating T cells. Blood 113, 622-625 (2009).
33. Dummer, W. et al. T cell homeostatic proliferation elicits effective antitumor autoimmunity. J. Clin. Invest. 110, 185-192 (2002). (Pubitemid 34787355)
34. Jeon, Y.H. et al. Immune response to frefy luciferase as a naked DNA. Cancer Biol. Ther. 6, 781-786 (2007).
35. Hutchins, G.D., Miller, M.A., Soon, V.C. & Receveur, T. Small animal PET imaging. ILAR J. 49, 54-65 (2008).
36. Hashemi, R.H. & Bradley, W.G. Jr. MRI: the Basics (Williams & Wilkins, 1997).
37. Farrar, T. & Becker, E. Pulse and Fourier Transform NMR-Introduction to Theory and Methods (Academic Press, 1971).
38. Akitt, J. & Mann, B. NMR and Chemistry: An Introduction to Modern NMR Spectroscopy (Stanley Thomes, 2000).
39. Kish, P.E. et al. Magnetic resonance imaging of ethyl-nitrosourea-induced rat gliomas: a model for experimental therapeutics of low-grade gliomas. J. Neurooncol. 53, 243-257 (2001). (Pubitemid 33034676)
40. Abdulkadir, S.A. et al. Impaired prostate tumorigenesis in Egr1-defcient mice. Nat. Med. 7, 101-107 (2001). (Pubitemid 32095648)
41. Cai, S.R. et al. A mouse model for developing treatment for secondary liver tumors. Int. J. Oncol. 27, 113-120 (2005).
42. Garbow, J.R., Wang, M., Wang, Y., Lubet, R.A. & You, M. Quantitative monitoring of adenocarcinoma development in rodents by magnetic resonance imaging. Clin. Cancer Res. 14, 1363-1367 (2008). (Pubitemid 351413916)
43. Garbow, J.R., Zhang, Z. & You, M. Detection of primary lung tumors in rodents by magnetic resonance imaging. Cancer Res. 64, 2740-2742 (2004). (Pubitemid 38500610)
44. Hedlund, L., Dewalt, S., Cofer, G. & Johnson, G.A. MR microscopy of the lung in Application of Magnetic Resonance to the Study of the Lung (ed. Cutillo, A.) 401-415 (Futura Press, 1996).
45. Anderson, M.W. et al. Effect of dietary green tea extract and aerosolized difuoromethylornithine during lung tumor progression in A/J strain mice. Carcinogenesis 29, 1594-1600 (2008).
46. Carreno, B.M. et al. Immunodefcient mouse strains display marked variability in growth of human melanoma lung metastases. Clin. Cancer Res. 15, 3277-3286 (2009).
47. Garbow, J.R. & Ackerman, J.J. Imaging primary lung cancers in mice to study radiation biology: in regard to Kirsch et al. (Int. J. Radiat. Oncol. Biol. Phys. 2010;76:973-977). Int. J. Radiat. Oncol. Biol. Phys. 79, 959 (2011).
48. Wang, Y. et al. Chemoprevention of lung squamous cell carcinoma in mice by a mixture of Chinese herbs. Cancer Prev. Res. 2, 634-640 (2009).
49. Tidwell, V.K., Garbow, J.R., Krupnick, A.S., Engelbach, J.A. & Nehorai, A. Quantitative analysis of tumor burden in mouse lung via MRI. Magn. Reson. Med. doi:10.1002/mrm.22951 (27 September 2011).
50. Garbow, J., Dugas, J., Song, S.-K. & Conradi, M. A simple, robust hardware device for passive or active respiratory gating in MRI and MRS experiments. Concepts Magn. Reson., Part B: Magn. Reson. Eng. 21B, 40-48 (2004). (Pubitemid 40646179)
51. Naish, J.H. et al. Modeling of contrast agent kinetics in the lung using T1-weighted dynamic contrast-enhanced MRI. Magn. Reson. Med. 61, 1507-1514 (2009).
52. Yuan, A. et al. Functional and structural characteristics of tumor angiogenesis in lung cancers overexpressing different VEGF isoforms assessed by DCE-and SSCE-MRI. PLoS One 6, e16062 (2011).
53. Ertel, D., Kyriakou, Y., Lapp, R.M. & Kalender, W.A. Respiratory phase-correlated micro-CT imaging of free-breathing rodents. Phys. Med. Biol. 54, 3837-3846 (2009).
54. Memon, A.A. et al. Positron emission tomography (PET) imaging with [11C]-labeled erlotinib: a micro-PET study on mice with lung tumor xenografts. Cancer Res. 69, 873-878 (2009).
55. Phenix, C.P. et al. Imaging of enzyme replacement therapy using PET. Proc. Natl. Acad. Sci. USA 107, 10842-10847 (2011).
56. Grimm, J. et al. Use of gene expression profling to direct in vivo molecular imaging of lung cancer. Proc. Natl. Acad. Sci. USA 102, 14404-14409 (2005). (Pubitemid 41429710)
57. Tung, C.H., Mahmood, U., Bredow, S. & Weissleder, R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res. 60, 4953-4958 (2000).
58. Vikis, H.G. et al. Strain-specifc susceptibility for pulmonary metastasis of sarcoma 180 cells in inbred mice. Cancer Res. 70, 4859-4867 (2010).
59. Yeh, H.H. et al. Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT. Proc. Natl. Acad. Sci. USA 108, 1603-1608 (2011).
60. Zhang, Y. et al. Identifcation of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay. Cancer Res. 69, 5867-5875 (2009).